Replacement_NN of_IN Candida_NP albicans_NNS with_IN C._NP dubliniensis_NN in_IN Human_NP Immunodeficiency_NN Virus-Infected_NP Patients_NPS with_IN Oropharyngeal_NP Candidiasis_NP Treated_NP with_IN Fluconazole_NP Candida_NP dubliniensis_NN is_VBZ an_DT opportunistic_JJ yeast_NN that_WDT has_VBZ been_VBN increasingly_RB implicated_VBN in_IN oropharyngeal_JJ candidiasis_NN (_( OPC_NP )_) in_IN human_JJ immunodeficiency_NN virus_NN (HIV)-infected_JJ patients_NNS but_CC may_MD be_VB underreported_VBN due_RB to_TO its_PP$ similarity_NN with_IN Candida_NP albicans_NNS ._SENT Although_IN most_JJS C._NP dubliniensis_NN isolates_NNS are_VBP susceptible_JJ to_TO fluconazole_NN ,_, the_DT inducibility_NN of_IN azole_NN resistance_NN in_IN vitro_NN has_VBZ been_VBN reported_VBN ._SENT Thus_RB ,_, the_DT use_NN of_IN fluconazole_NN prophylaxis_NN in_IN the_DT treatment_NN of_IN these_DT patients_NNS may_MD have_VB contributed_VBN to_TO the_DT increasing_VBG rates_NNS of_IN isolation_NN of_IN C._NP dubliniensis_NN ._SENT In_IN this_DT study_NN ,_, yeast_NN strains_NNS were_VBD collected_VBN from_IN the_DT oral_JJ cavities_NNS of_IN HIV-infected_JJ patients_NNS enrolled_VBN in_IN a_DT longitudinal_JJ study_NN of_IN OPC_NP ._SENT Patients_NNS received_VBD fluconazole_NN for_IN the_DT suppression_NN or_CC treatment_NN of_IN OPC_NP ,_, and_CC isolates_NNS collected_VBN at_IN both_DT study_NN entry_NN and_CC end_NN of_IN study_NN were_VBD chosen_VBN for_IN analysis_NN ._SENT Samples_NNS were_VBD plated_VBN on_IN CHROMagar_NP Candida_NP medium_NN for_IN initial_JJ isolation_NN and_CC further_RBR identified_VBN by_IN Southern_NP blot_NN analysis_NN with_IN the_DT species-specific_JJ probes_NNS Ca3_NN (_( for_IN C._NP albicans_NNS )_) and_CC Cd25_NP (_( for_IN C._NP dubliniensis_NN )_) ._SENT Fluconazole_NP MICs_NP were_VBD determined_VBN by_IN using_VBG NCCLS_NP methods_NNS ._SENT At_IN study_NN entry_NN ,_, susceptible_JJ C._NP albicans_NNS isolates_NNS were_VBD recovered_VBN from_IN oral_JJ samples_NNS in_IN 42_CD patients_NNS who_WP were_VBD followed_VBN longitudinally_RB (_( 1_CD to_TO 36_CD months_NNS )_) ._SENT C._NP albicans_NNS strains_NNS from_IN 12_CD of_IN these_DT patients_NNS developed_VBD fluconazole_NN resistance_NN (_( fluconazole_NP MIC_NP ,_, >=64_NN mug/ml_NN )_) ._SENT C._NP dubliniensis_NN was_VBD not_RB detected_VBN at_IN end_NN of_IN study_NN in_IN any_DT of_IN these_DT patients_NNS ._SENT Of_IN the_DT remaining_VBG 30_CD patients_NNS ,_, eight_CD (_( 27_CD %_NN )_) demonstrated_VBD a_DT replacement_NN of_IN C._NP albicans_NNS by_IN C._NP dubliniensis_NN when_WRB a_DT comparison_NN of_IN isolates_NNS obtained_VBN at_IN baseline_NN and_CC those_DT from_IN the_DT last_JJ culture_NN was_VBD done_VBN ._SENT For_IN the_DT 22_CD of_IN these_DT 30_CD patients_NNS in_IN whom_WP no_DT switch_NN in_IN species_NNS was_VBD detected_VBN ,_, the_DT fluconazole_NN MICs_NN for_IN initial_JJ and_CC end-of-study_JJ C._NP albicans_NNS isolates_NNS ranged_VBD from_IN 0.125_CD to_TO 2.0_CD mug/ml_NN ._SENT For_IN the_DT eight_CD patients_NNS in_IN whom_WP a_DT switch_NN to_TO C._NP dubliniensis_NN was_VBD detected_VBN ,_, the_DT fluconazole_NN MICs_NN for_IN C._NP dubliniensis_NN isolates_VBZ at_IN end_NN of_IN study_NN ranged_VBN from_IN 0.25_CD to_TO 64_CD mug/ml_NN :_: the_DT fluconazole_NN MICs_NN for_IN isolates_NNS from_IN six_CD patients_NNS were_VBD 0.25_CD to_TO 2.0_CD mug/ml_NN and_CC those_DT for_IN the_DT other_JJ two_CD were_VBD 32_CD and_CC 64_CD mug/ml_NN ,_, respectively_RB ._SENT In_IN conclusion_NN ,_, a_DT considerable_JJ number_NN of_IN patients_NNS initially_RB infected_VBN with_IN C._NP albicans_NNS strains_NNS that_WDT failed_VBD to_TO develop_VB fluconazole_NN resistance_NN demonstrated_VBD a_DT switch_NN to_TO C._NP dubliniensis_NN ._SENT C._NP dubliniensis_NN in_IN this_DT setting_NN may_MD be_VB underestimated_VBN due_RB to_TO lack_NN of_IN identification_NN and_CC may_MD occur_VB due_JJ to_TO the_DT impact_NN of_IN fluconazole_NN on_IN the_DT ecology_NN of_IN oral_JJ yeast_NN species_NNS ._SENT Candida_NP dubliniensis_NN is_VBZ a_DT causative_JJ agent_NN of_IN oropharyngeal_JJ candidiasis_NN (_( OPC_NP )_) in_IN human_JJ immunodeficiency_NN virus_NN (HIV)-infected_VBD and_CC AIDS_NP patients_NNS (_( 10_CD ,_, 34_CD ;_: D._NP C._NP Coleman_NP ,_, D._NP J._NP Sullivan_NP ,_, and_CC J._NP M._NP Mossman_NP ,_, Letter_NP ,_, J._NP Clin_NP ._SENT Microbiol_NP ._SENT 35:3011-3012_LS )_) ._SENT It_PP is_VBZ a_DT newly_RB identified_VBN species_NNS of_IN Candida_NP ,_, phenotypically_RB similar_JJ to_TO (_( chlamydospore_NN and_CC germ_NN tube_NN positive_JJ )_) ,_, but_CC genetically_RB distinct_JJ from_IN ,_, Candida_NP albicans_NNS (_( ,_, ,_, 36_CD )_) ._SENT Indeed_RB ,_, C._NP dubliniensis_NN was_VBD initially_RB difficult_JJ to_TO distinguish_VB from_IN C._NP albicans_NNS and_CC was_VBD often_RB misidentified_VBN as_IN such_JJ in_IN standard_JJ clinical_JJ laboratory_NN tests_NNS ,_, because_IN it_PP shares_VBZ phenotypic_JJ characteristics_NNS with_IN C._NP albicans_NNS ._SENT Thus_RB ,_, due_JJ to_TO the_DT phenotypic_JJ similarity_NN of_IN the_DT two_CD organisms_NNS ,_, there_EX is_VBZ a_DT growing_VBG body_NN of_IN evidence_NN suggesting_VBG that_IN many_JJ previous_JJ cases_NNS of_IN OPC_NP thought_VBD to_TO have_VB been_VBN caused_VBN by_IN C._NP albicans_NNS were_VBD in_IN reality_NN caused_VBN by_IN C._NP dubliniensis_NN ._SENT Since_IN its_PP$ identification_NN as_IN an_DT etiologic_JJ agent_NN of_IN OPC_NP ,_, C._NP dubliniensis_NN has_VBZ received_VBN increasing_VBG attention_NN ._SENT Although_IN it_PP was_VBD initially_RB implicated_VBN in_IN OPC_NP in_IN HIV-infected_JJ patients_NNS ,_, particularly_RB those_DT with_IN recurrent_JJ infections_NNS ,_, C._NP dubliniensis_NN has_VBZ since_RB been_VBN found_VBN to_TO be_VB both_CC an_DT oral_JJ carriage_NN organism_NN and_CC a_DT causative_JJ agent_NN of_IN oral_JJ candidiasis_NN in_IN HIV-negative_JJ individuals_NNS (_( -_: ,_, ,_, ,_, -_: ,_, ,_, ,_, ,_, ,_, -_: ;_: Coleman_NP et_FW al._FW ,_, letter_NN )_) ._SENT The_DT interaction_NN and_CC ecological_JJ relationships_NNS of_IN different_JJ Candida_NP species_NNS in_IN the_DT oropharynx_NN are_VBP not_RB completely_RB understood_VBN and_CC appropriately_RB constitute_VBP a_DT topic_NN of_IN active_JJ research_NN ._SENT In_IN a_DT recent_JJ study_NN that_WDT examined_VBD the_DT growth_NN competition_NN between_IN C._NP albicans_NP and_CC C._NP dubliniensis_NN under_IN broth_NN and_CC biofilm_NN growth_NN conditions_NNS ,_, it_PP was_VBD shown_VBN that_IN C._NP albicans_NNS had_VBD a_DT competitive_JJ advantage_NN over_IN C._NP dubliniensis_NN ._SENT The_DT clinical_JJ significance_NN of_IN this_DT organism_NN is_VBZ yet_RB to_TO be_VB determined_VBN ,_, but_CC it_PP has_VBZ been_VBN demonstrated_VBN that_IN ,_, contrary_JJ to_TO fluconazole_VB (_( FLU_NP )_) resistance_NN in_IN C._NP albicans_NNS ,_, FLU_NP resistance_NN in_IN C._NP dubliniensis_NN is_VBZ easily_RB inducible_JJ in_IN vitro_NN ._SENT Thus_RB ,_, prolonged_JJ use_NN of_IN FLU_NP in_IN HIV-infected_JJ patients_NNS may_MD impact_VB the_DT epidemiology_NN of_IN OPC_NP ._SENT The_DT present_JJ study_NN was_VBD undertaken_VBN to_TO further_RBR define_VB the_DT complex_JJ microbial_JJ ecology_NN in_IN the_DT oropharynxes_NNS of_IN HIV-infected_JJ patients_NNS exposed_VBN to_TO FLU_NP for_IN the_DT treatment_NN of_IN OPC_NP and_CC to_TO increase_VB our_PP$ understanding_NN of_IN the_DT role_NN of_IN C._NP dubliniensis_NN in_IN OPC_NP ._SENT Clinical_JJ samples_NNS ._SENT |_SYM Yeast_NP isolates_NNS were_VBD recovered_VBN from_IN swabs_NNS and/or_CC oral_JJ rinses_NNS taken_VBN from_IN the_DT oropharynxes_NNS of_IN HIV-infected_JJ patients_NNS enrolled_VBN in_IN a_DT longitudinal_JJ study_NN to_TO assess_VB the_DT development_NN of_IN FLU_NP resistance_NN ._SENT Sixty-four_NP patients_NNS were_VBD enrolled_VBN and_CC monitored_VBN clinically_RB for_IN the_DT presence_NN of_IN OPC_NP ._SENT Cultures_NNS of_IN the_DT oropharynx_NN were_VBD obtained_VBN at_IN the_DT time_NN of_IN enrollment_NN and_CC either_RB during_IN times_NNS of_IN clinical_JJ OPC_NP or_CC at_IN quarterly_JJ intervals_NNS if_IN OPC_NP was_VBD not_RB present_JJ ._SENT All_DT patients_NNS were_VBD treated_VBN initially_RB with_IN FLU_NP at_IN a_DT dose_NN of_IN 100_CD mg/day_NN ._SENT Doses_NNS of_IN FLU_NP were_VBD increased_VBN up_RP to_TO 800_CD mg/day_NN in_IN those_DT individuals_NNS who_WP developed_VBD clinical_JJ resistance_NN ,_, which_WDT is_VBZ defined_VBN as_IN the_DT clinical_JJ requirement_NN for_IN increasing_VBG FLU_NP doses_NNS for_IN response_NN (_( ,_, -_: )_) ._SENT All_DT oral_JJ samples_NNS were_VBD screened_VBN with_IN the_DT chromogenic_JJ medium_NN CHROMagar_NP Candida_NP (_( CHROMagar_NP Company_NP ,_, Paris_NP ,_, France_NP )_) and_CC initially_RB identified_VBN as_IN C._NP albicans_NNS by_IN colony_NN color_NN and_CC a_DT positive_JJ germ_NN tube_NN test_NN in_IN serum_NN ._SENT Selected_VBN yeast_NN isolates_NNS included_VBD those_DT obtained_VBN on_IN both_DT initial_JJ and_CC final_JJ cultures_NNS from_IN these_DT patients_NNS ._SENT Susceptibility_NN testing_NN ._SENT |_SYM Candida_NP isolates_NNS were_VBD tested_VBN for_IN susceptibility_NN to_TO FLU_NP in_IN accordance_NN with_IN NCCLS_NP methods_NNS ._SENT Candida_NP isolates_NNS were_VBD considered_VBN susceptible_JJ (_( MIC_NP ,_, 8_CD mug/ml_NN )_) ,_, susceptible_JJ dose_NN dependent_NN (_( MIC_NP ,_, 16_CD to_TO 32_CD mug/ml_NN )_) ,_, or_CC resistant_JJ (_( MIC_NP ,_, >=64_NN mug/ml_NN )_) ._SENT All_DT antifungal_JJ susceptibility_NN testing_NN was_VBD performed_VBN at_IN the_DT Fungal_NP Testing_NP Laboratory_NP ,_, University_NP of_IN Texas_NP Health_NP Science_NP Center_NP San_NP Antonio_NP ,_, San_NP Antonio_NP ._SENT DNA_NP typing_VBG techniques_NNS ._SENT |_SYM Electrophoretic_JJ karyotype_NN and_CC fingerprinting_VBG analyses_NNS of_IN EcoRI-digested_JJ chromosomal_JJ DNA_NN with_IN the_DT repetitive_JJ probes_NNS Ca3_JJ ,_, specific_JJ for_IN C._NP albicans_NNS ,_, and_CC Cd25_NP ,_, specific_JJ for_IN C._NP dubliniensis_NN ,_, were_VBD performed_VBN as_IN previously_RB described_VBN ._SENT Hybridization_NN with_IN probes_NNS Ca3_NP and_CC Cd25_NP was_VBD also_RB used_VBN as_IN a_DT genotypic_JJ tool_NN to_TO confirm_VB the_DT identity_NN of_IN the_DT isolates_NNS as_IN C._NP albicans_NP or_CC C._NP dubliniensis_NN ,_, respectively_RB ._SENT In_IN brief_JJ ,_, chromosomal_JJ DNA_NN from_IN each_DT isolate_NN was_VBD prepared_VBN in_IN agarose_JJ plugs_NNS and_CC separated_VBN by_IN pulsed-field_JJ gel_NN electrophoresis_NN (_( Bio-Rad_NP ,_, Hercules_NP ,_, Calif._NP )_) ._SENT Restriction_NN fragment_NN length_NN polymorphism_NN patterns_NNS were_VBD obtained_VBN by_IN digestion_NN of_IN chromosomal_JJ DNA_NN by_IN using_VBG SfiI_NP and_CC EcoRI_NP (_( Boehringer-Mannheim_NP ,_, Indianapolis_NP ,_, Ind._NP )_) ._SENT Digested_VBN DNA_NN present_NN in_IN the_DT restriction_NN fragment_NN length_NN polymorphism_NN gels_NNS was_VBD transferred_VBN to_TO nylon_NN membranes_NNS (_( Nytran_NP ;_: Schleicher_NP and_CC Schuell_NP ,_, Keene_NP ,_, N.H._NP )_) and_CC hybridized_VBN with_IN probe_NN Ca3_NP and_CC subsequently_RB with_IN probe_NN Cd25_NP (_( after_IN removal_NN of_IN the_DT bound_JJ probe_NN Ca3_NP )_) ,_, radioactively_RB labeled_VBN by_IN random_JJ priming_NN (_( Random_NP Primers_NP DNA_NP labeling_VBG system_NN ;_: GibcoBRL_NP ,_, Gaithersburg_NP ,_, Md._NP )_) ,_, and_CC exposed_VBN to_TO autoradiography_NN film_NN (_( Du_NP Pont_NP ,_, Wilmington_NP ,_, Del._NP )_) overnight_RB at_IN -70C_NN ._SENT Of_IN the_DT 64_CD patients_NNS enrolled_VBN in_IN the_DT study_NN ,_, initial_JJ cultures_NNS of_IN the_DT oropharynx_NN specimens_NNS from_IN 42_CD demonstrated_VBD FLU-susceptible_NP C._NP albicans_NP isolates_VBZ ._SENT Of_IN these_DT 42_CD patients_NNS ,_, 12_CD developed_VBN FLU-resistant_NP (_( FLU_NP MIC_NP ,_, >=64_NN mug/ml_NN )_) C._NP albicans_NNS on_IN their_PP$ final_JJ cultures_NNS (_( species_NN identity_NN for_IN all_DT resistant_JJ isolates_NNS was_VBD confirmed_VBN at_IN the_DT DNA_NP level_NN )_) while_IN 30_CD patients_NNS did_VBD not_RB ._SENT Upon_IN further_JJR evaluation_NN of_IN all_DT final_JJ isolates_NNS from_IN these_DT 30_CD patients_NNS ,_, eight_CD patients_NNS whose_WP$ initial_JJ cultures_NNS had_VBD demonstrated_VBN a_DT FLU-susceptible_NP C._NP albicans_NNS isolate_NN showed_VBD a_DT change_NN to_TO a_DT C._NP dubliniensis_NN isolate_NN at_IN end_NN of_IN study_NN ,_, as_RB shown_VBN in_IN Table_NP ._SENT C._NP dubliniensis_NN isolates_NNS were_VBD susceptible_JJ to_TO FLU_NP at_IN MICs_NP ranging_VBG from_IN 0.25_CD to_TO 64_CD mug/ml_NN ._SENT The_DT FLU_NP MICs_NP for_IN six_CD isolates_NNS were_VBD 0.25_CD to_TO 2.0_CD mug/ml_NN ,_, while_IN those_DT for_IN two_CD other_JJ isolates_NNS were_VBD 32_CD and_CC 64_CD mug/ml_NN ,_, respectively_RB ._SENT Strain_NN delineation_NN of_IN isolates_NNS was_VBD performed_VBN by_IN electrophoretic_JJ karyotype_NN analysis_NN ,_, as_RB shown_VBN in_IN Fig._NN ._SENT All_DT initial_JJ isolates_NNS demonstrated_VBD chromosomal_JJ banding_VBG patterns_NNS consistent_JJ with_IN that_DT of_IN C._NP albicans_NNS ._SENT These_DT patterns_NNS ,_, however_RB ,_, were_VBD distinctly_RB different_JJ from_IN those_DT obtained_VBN for_IN the_DT end-of-study_NN ,_, or_CC final_JJ ,_, isolates_VBZ ._SENT Final_JJ isolates_NNS (_( Fig._NN ,_, lanes_NNS B_NN )_) all_RB demonstrated_VBD a_DT distinct_JJ low-molecular-weight_NN band_NN that_WDT was_VBD not_RB found_VBN for_IN any_DT of_IN the_DT initial_JJ isolates_NNS ,_, which_WDT is_VBZ characteristic_JJ of_IN C._NP dubliniensis_NN ._SENT Fingerprinting_VBG analysis_NN with_IN the_DT probes_NNS specific_JJ for_IN C._NP albicans_NP (_( Ca3_NP )_) and_CC C._NP dubliniensis_NP (_( Cd25_NP )_) are_VBP shown_VBN in_IN Fig._NN and_CC ,_, respectively_RB ._SENT As_IN shown_VBN in_IN Fig._NN ,_, all_DT initial_JJ isolates_NNS hybridized_VBN with_IN Ca3_NP ,_, as_RB demonstrated_VBN by_IN autoradiography_NN ,_, while_IN none_NN of_IN the_DT final_JJ isolates_NNS demonstrated_VBD hybridization_NN activity_NN ._SENT In_IN Fig._NN ,_, however_RB ,_, the_DT converse_NN is_VBZ true_JJ ._SENT None_NN of_IN the_DT initial_JJ isolates_NNS hybridized_VBN with_IN Cd25_NP ,_, while_IN each_DT of_IN the_DT final_JJ isolates_NNS demonstrated_VBD reactivity_NN ._SENT These_DT hybridization_NN patterns_NNS showed_VBD that_IN all_DT initial_JJ isolates_NNS were_VBD C._NP albicans_NNS and_CC all_DT final_JJ isolates_NNS were_VBD C._NP dubliniensis_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Electrophoretic_JJ karyotype_NN analysis_NN results_NNS for_IN Candida_NP isolates_VBZ from_IN eight_CD patients_NNS in_IN whom_WP the_DT culture_NN isolate_NN changed_VBN from_IN C._NP albicans_NP Electrophoretic_NP karyotype_NN analysis_NN results_NNS for_IN Candida_NP isolates_VBZ from_IN eight_CD patients_NNS in_IN whom_WP the_DT culture_NN isolate_NN changed_VBN from_IN C._NP albicans_NNS to_TO C._NP dubliniensis_NN ._SENT Patient_JJ numbers_NNS are_VBP given_VBN at_IN the_DT top_NN of_IN the_DT figure_NN ._SENT Lanes_NNS :_: A_DT ,_, initial_JJ isolates_NNS ;_: B_NP ,_, final_JJ isolates_NNS ._SENT FLU_NN MICs_NNS are_VBP in_IN micrograms_NNS per_IN milliliter_NN ._SENT FIG._NN 2_CD ._SENT |_SYM DNA_NN fingerprinting_VBG analysis_NN of_IN EcoRI-digested_JJ chromosomal_JJ DNA_NN with_IN the_DT radiolabeled_JJ Ca3_NP probe_NN ,_, which_WDT is_VBZ specific_JJ for_IN C._NP albicans_NNS ._SENT DNA_NN fingerprinting_VBG analysis_NN of_IN EcoRI-digested_JJ chromosomal_JJ DNA_NN with_IN the_DT radiolabeled_JJ Ca3_NP probe_NN ,_, which_WDT is_VBZ specific_JJ for_IN C._NP albicans_NNS ._SENT Patient_JJ numbers_NNS are_VBP given_VBN at_IN the_DT top_NN of_IN the_DT figure_NN ._SENT Lanes_NNS :_: A_DT ,_, initial_JJ isolates_NNS ;_: B_NP ,_, final_JJ isolates_NNS ._SENT FLU_NN MICs_NNS are_VBP in_IN micrograms_NNS per_IN milliliter_NN ._SENT FIG._NN 3_CD ._SENT |_SYM DNA_NN fingerprinting_VBG analysis_NN of_IN EcoRI-digested_JJ chromosomal_JJ DNA_NN with_IN the_DT radiolabeled_JJ Cd25_NP probe_NN ,_, which_WDT is_VBZ specific_JJ for_IN C._NP dubliniensis_NN ._SENT DNA_NN fingerprinting_VBG analysis_NN of_IN EcoRI-digested_JJ chromosomal_JJ DNA_NN with_IN the_DT radiolabeled_JJ Cd25_NP probe_NN ,_, which_WDT is_VBZ specific_JJ for_IN C._NP dubliniensis_NN ._SENT Patient_JJ numbers_NNS are_VBP given_VBN at_IN the_DT top_NN of_IN the_DT figure_NN Lanes_NP :_: A_DT ,_, initial_JJ isolates_NNS ;_: B_NP ,_, final_JJ isolates_NNS ._SENT FLU_NN MICs_NNS are_VBP in_IN micrograms_NNS per_IN milliliter_NN ._SENT TABLE_NN 1_CD |_SYM Initial_JJ and_CC end-of-study_JJ culture_NN isolates_VBZ from_IN 30_CD patients_NNS and_CC their_PP$ FLU_NP susceptibilities_NNS The_DT increased_VBN use_NN of_IN antifungal_JJ agents_NNS (_( mainly_RB FLU_NP )_) may_MD be_VB responsible_JJ for_IN the_DT development_NN of_IN more_RBR highly_RB resistant_JJ microorganisms_NNS and_CC may_MD impact_VB the_DT ecology_NN of_IN oral_JJ yeast_NN species_NNS by_IN effecting_VBG a_DT shift_NN toward_IN species_NNS with_IN innate_JJ resistance_NN or_CC those_DT that_WDT are_VBP more_RBR prone_JJ to_TO develop_VB resistance_NN to_TO drugs_NNS such_JJ as_IN FLU_NP ._SENT Although_IN most_JJS C._NP dubliniensis_NN clinical_JJ isolates_NNS are_VBP susceptible_JJ to_TO azole_NN derivatives_NNS ,_, our_PP$ group_NN and_CC others_NNS have_VBP reported_VBN the_DT isolation_NN of_IN FLU-resistant_NP C._NP dubliniensis_NN clinical_JJ isolates_NNS from_IN the_DT oral_JJ cavities_NNS of_IN HIV-infected_JJ patients_NNS with_IN OPC_NP and_CC prior_JJ exposure_NN to_TO FLU_NP ._SENT In_IN addition_NN ,_, derivatives_NNS exhibiting_VBG a_DT stable_JJ FLU-resistant_JJ phenotype_NN can_MD be_VB readily_RB generated_VBN in_IN vitro_NN from_IN FLU-susceptible_JJ isolates_NNS ,_, a_DT phenomenon_NN that_WDT is_VBZ not_RB easily_RB observed_VBN with_IN C._NP albicans_NNS ,_, thus_RB indicating_VBG that_DT C._NP dubliniensis_NN may_MD display_VB a_DT higher_JJR propensity_NN to_TO develop_VB azole_NN resistance_NN than_IN C._NP albicans_NNS ._SENT Our_PP$ results_NNS indicate_VBP that_IN replacement_NN of_IN C._NP albicans_NNS by_IN C._NP dubliniensis_NN occurred_VBD in_IN a_DT considerable_JJ number_NN (_( 27_CD %_NN )_) of_IN patients_NNS treated_VBN with_IN FLU_NP who_WP failed_VBD to_TO develop_VB FLU-resistant_NP C._NP albicans_NNS ._SENT Of_IN note_NN ,_, virtually_RB all_RB of_IN these_DT isolates_NNS were_VBD initially_RB identified_VBN incorrectly_RB as_IN C._NP albicans_NNS by_IN the_DT phenotypic_JJ methods_NNS routinely_RB used_VBN in_IN our_PP$ laboratory_NN ,_, and_CC only_RB subsequent_JJ use_NN of_IN genotypic_JJ methods_NNS (_( karyotyping_NP and_CC Cd25_NP fingerprinting_VBG )_) allowed_VBD correct_JJ identification_NN of_IN the_DT isolates_NNS as_IN C._NP dubliniensis_NN ._SENT For_IN the_DT patients_NNS in_IN the_DT present_JJ study_NN ,_, the_DT FLU_NP MICs_NP for_IN initial_JJ and_CC end-of-study_JJ C._NP albicans_NNS isolates_VBZ from_IN those_DT who_WP did_VBD not_RB exhibit_VB a_DT change_NN in_IN species_NNS (_( n_NN =_SYM 22_LS )_) ranged_VBN from_IN 0.125_CD to_TO 2.0_CD mug/ml_NN whereas_IN the_DT FLU_NP MICs_NP for_IN C._NP dubliniensis_NN isolates_VBZ from_IN end-of-study_NN cultures_NNS for_IN eight_CD patients_NNS ranged_VBN from_IN 0.25_CD to_TO 64_CD mug/ml_NN ._SENT Interestingly_RB ,_, replacement_NN of_IN C._NP albicans_NNS by_IN C._NP dubliniensis_NN was_VBD not_RB observed_VBN in_IN patients_NNS whose_WP$ C._NP albicans_NNS strains_NNS were_VBD able_JJ to_TO develop_VB FLU_NP resistance_NN ._SENT These_DT results_NNS suggest_VBP that_IN the_DT antifungal_JJ pressure_NN exerted_VBN by_IN prolonged_JJ FLU_NP treatment_NN influences_VBZ the_DT oral_JJ microbial_JJ ecology_NN in_IN these_DT patients_NNS ._SENT Species_NNS that_WDT are_VBP better_RBR able_JJ to_TO adapt_VB to_TO the_DT antifungal_JJ pressure_NN may_MD persist_VB over_IN those_DT that_WDT are_VBP effectively_RB suppressed_VBN by_IN the_DT treatment_NN ._SENT However_RB ,_, persistence_NN of_IN oral_JJ microorganisms_NNS as_IN commensal_JJ or_CC infectious_JJ organisms_NNS may_MD also_RB depend_VB on_IN other_JJ factors_NNS not_RB related_VBN to_TO resistance_NN ._SENT Indeed_RB ,_, the_DT majority_NN of_IN C._NP dubliniensis_NN isolates_NNS recovered_VBD at_IN the_DT end_NN of_IN study_NN did_VBD not_RB demonstrate_VB decreased_VBN susceptibility_NN to_TO FLU_NP ._SENT We_PP have_VBP previously_RB demonstrated_VBN that_IN ,_, in_IN the_DT absence_NN of_IN antifungal_JJ pressure_NN ,_, C._NP albicans_NNS predominates_VBZ over_IN C._NP dubliniensis_NN in_IN normal_JJ growth_NN competition_NN assays_NNS ._SENT However_RB ,_, adherent_JJ populations_NNS of_IN C._NP dubliniensis_NN were_VBD able_JJ to_TO withstand_VB the_DT competitive_JJ pressure_NN of_IN C._NP albicans_NNS ._SENT Some_DT factors_NNS that_WDT may_MD also_RB favor_VB the_DT survival_NN of_IN C._NP dubliniensis_NN in_IN the_DT oral_JJ cavity_NN are_VBP its_PP$ intrinsic_JJ cell_NN surface_NN hydrophobicity_NN ,_, its_PP$ ability_NN to_TO bind_VB to_TO oral_JJ bacteria_NNS ,_, and_CC its_PP$ ability_NN to_TO form_VB biofilms_NNS ._SENT The_DT presence_NN of_IN subinhibitory_JJ concentrations_NNS of_IN FLU_NP may_MD alter_VB these_DT properties_NNS ._SENT These_DT factors_NNS ,_, together_RB with_IN better_JJR identification_NN techniques_NNS ,_, may_MD be_VB responsible_JJ for_IN the_DT increasing_VBG rates_NNS of_IN isolation_NN of_IN this_DT newly_RB described_VBN species_NNS ._SENT In_IN summary_NN ,_, in_IN our_PP$ longitudinal_JJ study_NN of_IN FLU_NP resistance_NN in_IN HIV-infected_JJ patients_NNS ,_, for_IN a_DT considerable_JJ number_NN of_IN patients_NNS initially_RB infected_VBN with_IN C._NP albicans_NNS strains_NNS that_WDT failed_VBD to_TO develop_VB FLU_NP resistance_NN (_( more_JJR than_IN one-fourth_NN )_) ,_, later_JJR cultures_NNS showed_VBD a_DT change_NN in_IN species_NNS isolated_VBN to_TO C._NP dubliniensis_NN ._SENT Identification_NN of_IN C._NP dubliniensis_NN required_VBD the_DT use_NN of_IN genotypic_JJ methods_NNS ._SENT Thus_RB ,_, C._NP dubliniensis_NN in_IN this_DT setting_NN may_MD be_VB underestimated_VBN due_RB to_TO lack_NN of_IN proper_JJ identification_NN and_CC may_MD occur_VB ,_, in_IN part_NN ,_, because_IN of_IN the_DT impact_NN of_IN FLU_NP therapy_NN on_IN the_DT ecology_NN of_IN oral_JJ yeast_NN species_NNS ._SENT 